GNH USA

Europe — EMA

Pandiol (Granisetron)

Granisetron, the active ingredient in Pandiol, is a 5‑HT3 receptor antagonist presented as a unknown/unknown for unknown use. It treats and prevents nausea and vomiting associated with chemotherapy, radiation therapy…

Request sourcing

1
Pack/s

What is Granisetron?

Granisetron, the active ingredient in Pandiol, is a 5‑HT3 receptor antagonist presented as a unknown/unknown for unknown use. It treats and prevents nausea and vomiting associated with chemotherapy, radiation therapy, and surgery.

GNH USA supplies Pandiol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

What is Granisetron used for?

Granisetron is a selective 5‑HT3 receptor antagonist that helps the body to manage the nausea and vomiting pathways of the following conditions: - Chemotherapy‑   :            ...   …  ... . -       ...  …  ...  ... ....  ...  ....  ... … … …  ... ...  

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Granisetron
Route
Oral Use
Manufacturer
Elleva Pharma S.R.L.
Origin
EU

Related products